Is the epilepsy drug market about to shrink? Ian Mundell Newsletter Article 15 February 2013 Pages: 3 - 4
BCG may be an option in refractory interstitial cystitis Newsletter Article 15 February 2013 Pages: 8 - 8
Finding the real answers to scleroderma Rachel Webber Newsletter Article 15 February 2013 Pages: 9 - 10
Vitamin D receptor gene predicts risk for osteoporosis Newsletter Article 15 February 2013 Pages: 10 - 10
Plant product has ‘great potential’ as an antineoplastic Newsletter Article 15 February 2013 Pages: 11 - 11
Moclobemide for outpatient treatment of depression Newsletter Article 15 February 2013 Pages: 12 - 12
Putting the DCCT into practice - the UK way Robert Short Newsletter Article 15 February 2013 Pages: 13 - 13
Post-op ketorolac has ‘modest’ opioid-sparing effect Newsletter Article 15 February 2013 Pages: 14 - 14
Fluconazole prophylaxis beneficial in neutropenic patients with cancer Newsletter Article 15 February 2013 Pages: 15 - 15
Combined treatment a possibility for comorbid OCD/Tourette’s Newsletter Article 15 February 2013 Pages: 16 - 16
Optimising combination therapy in children with HIV Newsletter Article 15 February 2013 Pages: 17 - 17
Antihypertensives - how well do they work for elderly women? Newsletter Article 15 February 2013 Pages: 17 - 17
Misuse of antibacterials in China - urgent attention needed Newsletter Article 15 February 2013 Pages: 19 - 19
Outpatient antineoplastic therapy for nasopharyngeal cancer Newsletter Article 15 February 2013 Pages: 19 - 19
Intravaginal clindamycin beneficial in bacterial vaginosis Newsletter Article 15 February 2013 Pages: 19 - 19
Lipoprotein (a) levels can’t be blamed on your (sex) hormones Newsletter Article 15 February 2013 Pages: 20 - 20
Improved collagen quality after estradiol in osteoporosis Newsletter Article 15 February 2013 Pages: 20 - 20